S. Urba

发表

Phase II evaluation of sorafenib in advanced and metastatic squamous cell carcinoma of the head and neck: Southwest Oncology Group Study S0420.

M. Leblanc, J. Moon, G. Wolf, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Survivorship, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology.

A. King, J. Montoya, Deborah A. Freedman-Cass, 2018, Journal of the National Comprehensive Cancer Network : JNCCN.

Advanced squamous cell carcinoma of the oropharynx: Efficacy of positron emission tomography and computed tomography for determining primary tumor response during induction chemotherapy

K. Frey, S. Mukherji, A. Eisbruch, 2009, Head & neck.

Infiltrating lymphocytes and human papillomavirus‐16–associated oropharyngeal cancer

Jeremy MG Taylor, Dafydd G. Thomas, A. Eisbruch, 2012, The Laryngoscope.

Locally Advanced, Unresectable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline.

A. Khorana, M. Shah, A. Benson, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Combined-modality treatment of esophageal cancer.

S. Urba, 1997, Oncology.

Neoadjuvant Therapy for Organ Preservation in Head and Neck Cancer

M. Strawderman, A. Eisbruch, C. Bradford, 2000, The Laryngoscope.

NCCN Guidelines Insights: Survivorship, Version 2.2019.

Deborah A. Freedman-Cass, W. Demark-Wahnefried, M. Hudson, 2019, Journal of the National Comprehensive Cancer Network : JNCCN.

NCCN Guidelines Insights: Survivorship, Version 2.2019.

Deborah A. Freedman-Cass, W. Demark-Wahnefried, M. Hudson, 2019, Journal of the National Comprehensive Cancer Network : JNCCN.

Experimental therapeutic approaches for recurrent head and neck cancer.

A. Forastiere, S. Urba, 1995, Cancer treatment and research.

Systemic therapy of head and neck cancer: most effective agents, areas of promise.

A. Forastiere, S. Urba, 1989, Oncology.

Organ preservation in advanced head and neck cancer.

G. Wolf, S. Urba, C. R. Dibb, 1995, Cancer treatment and research.

Predictors of overall and recurrence-free survival after neoadjuvant chemotherapy for gastroesophageal adenocarcinoma: Pooled analysis of individual patient data (IPD) from randomized controlled trials (RCTs).

M. Ychou, C. V. D. van de Velde, P. Kienle, 2017, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Preoperative chemo(radio)therapy versus primary surgery for gastroesophageal adenocarcinoma: systematic review with meta-analysis combining individual patient and aggregate data.

M. Ychou, C. V. D. van de Velde, P. Kienle, 2013, European journal of cancer.

Esophageal cancer: preoperative or definitive chemoradiation.

S. Urba, 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

Concurrent cisplatin, paclitaxel, and radiotherapy as preoperative treatment for patients with locoregional esophageal carcinoma

M. Orringer, J. Hayman, S. Urba, 2003, Cancer.

Randomized Tria l o f Preoperat i ve Chemoradiat ion Versus Surgery Alone in Pat ients With Locoregional Esophageal Carc inoma

M. Iannettoni, M. Orringer, M. Strawderman, 2000 .

Concurrent preoperative chemotherapy and radiation therapy in localized esophageal adenocarcinoma

M. Orringer, A. Forastiere, C. Perez-Tamayo, 1992, Cancer.

Targeting apoptosis to overcome cisplatin resistance: a translational study in head and neck cancer.

Jeremy MG Taylor, K. Griffith, Shaomeng Wang, 2007, International journal of radiation oncology, biology, physics.

Survivorship: fatigue, version 1.2014.

A. King, J. Montoya, Deborah A. Freedman-Cass, 2014, Journal of the National Comprehensive Cancer Network : JNCCN.

Radiation concurrent with gemcitabine for locally advanced head and neck cancer: a phase I trial and intracellular drug incorporation study.

L. Dawson, T. Lawrence, A. Eisbruch, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A phase II study of bevacizumab, oxaliplatin, and docetaxel in locally advanced and metastatic gastric and gastroesophageal junction cancers.

P. Philip, A. Shields, D. Smith, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

Preoperative chemoradiation followed by transhiatal esophagectomy for carcinoma of the esophagus: final report.

M. Orringer, M. Zahurak, A. Forastiere, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Disease-free survival as a surrogate for overall survival in neoadjuvant trials of gastroesophageal adenocarcinoma: Pooled analysis of individual patient data from randomised controlled trials.

M. Ychou, C. V. D. van de Velde, M. Kieser, 2019, European journal of cancer.

Weekly chemotherapy with radiation versus high‐dose cisplatin with radiation as organ preservation for patients with HPV‐positive and HPV‐negative locally advanced squamous cell carcinoma of the oropharynx

F. Feng, A. Eisbruch, T. Carey, 2014, Head & neck.

Chemotherapy alone for organ preservation in advanced laryngeal cancer

C. Tsien, A. Eisbruch, C. Bradford, 2009, Head & neck.

Chemoselection as a strategy for organ preservation in patients with T4 laryngeal squamous cell carcinoma with cartilage invasion

S. Mukherji, C. Tsien, A. Eisbruch, 2009, The Laryngoscope.

Multicenter phase II trial of brequinar sodium in patients with advanced squamous-cell carcinoma of the head and neck

J. Doroshow, S. Urba, C. Cripps, 2004, Cancer Chemotherapy and Pharmacology.

Response to therapy and outcomes in oropharyngeal cancer are associated with biomarkers including human papillomavirus, epidermal growth factor receptor, gender, and smoking.

Jeremy MG Taylor, C. Tsien, A. Eisbruch, 2007, International journal of radiation oncology, biology, physics.

Organ preservation for advanced resectable cancer of the base of tongue and hypopharynx: a Southwest Oncology Group Trial.

M. Leblanc, J. Moon, J. Ensley, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Neoadjuvant therapy.

W. Liggett, A. Forastiere, S. Urba, 2020, The cancer journal from Scientific American.

Survivorship: nutrition and weight management, Version 2.2014. Clinical practice guidelines in oncology.

A. King, J. Montoya, Deborah A. Freedman-Cass, 2014, Journal of the National Comprehensive Cancer Network : JNCCN.

Adult Cancer Pain: Clinical Practice Guidelines in Oncology

C. Benedetti, A. Abernethy, C. Cleeland, 2010 .

Quality of life scores as prognostic factors of overall survival in advanced head and neck cancer: analysis of a phase III randomized trial of pemetrexed plus cisplatin versus cisplatin monotherapy.

W. Shen, E. Cohen, A. Hossain, 2012, Oral oncology.

NCCN clinical practice guidelines in oncology: palliative care.

C. Benedetti, J. V. Von Roenn, C. Ritchie, 2009, Journal of the National Comprehensive Cancer Network : JNCCN.

Chemotherapy and radiation therapy before transhiatal esophagectomy for esophageal carcinoma.

M. Orringer, A. Forastiere, C. Perez-Tamayo, 1990, The Annals of thoracic surgery.

Survivorship: healthy lifestyles, version 2.2014.

A. King, J. Montoya, Deborah A. Freedman-Cass, 2014, Journal of the National Comprehensive Cancer Network : JNCCN.

Metabolic abnormalities associated with weight loss during chemoirradiation of head-and-neck cancer.

M. Schipper, C. Tsien, J. Liao, 2005, International journal of radiation oncology, biology, physics.

Chemotherapy in head and neck cancer. Overview of newer agents.

S. Urba, J. Khattab, 1999, Hematology/oncology clinics of North America.

Palliative care. Clinical practice guidelines in oncology.

C. Benedetti, J. V. Von Roenn, S. Block, 2006, Journal of the National Comprehensive Cancer Network : JNCCN.

Predictive factors in patients with advanced and metastatic squamous cell carcinoma of the head and neck: A study based on SWOG protocol S0420

M. Leblanc, J. Moon, G. Wolf, 2013, Oncology reports.

One cycle of induction chemotherapy (IC) in advanced oropharyngeal cancer (SCCOP) to select patients for organ preservation (OP)

C. Tsien, A. Eisbruch, T. Carey, 2005 .

A phase II evaluation of a 3‐hour infusion of paclitaxel, cisplatin, and 5‐fluorouracil in patients with advanced or recurrent squamous cell carcinoma of the head and neck

S. Dakhil, J. Moon, W. Samlowski, 2006, Cancer.

A phase II trial of sorafenib in patients with recurrent and/or metastatic head and neck squamous cell carcinoma (HNSCC): A Southwest Oncology Group (SWOG) trial

J. Moon, G. Wolf, C. Huang, 2006 .

Retrobulbar neuritis in a patient treated with intraarterial cisplatin for head and neck cancer

A. Forastiere, S. Urba, 1988, Cancer.

Antiemesis. Clinical Practice Guidelines in Oncology.

P. Bierman, D. Ettinger, M. Kris, 2004, Journal of the National Comprehensive Cancer Network : JNCCN.

NCCN Practice Guidelines for Head and Neck Cancers.

R H Wheeler, J. Shah, W. Hong, 2000, Oncology.

Assessing fear of recurrence of esophageal cancer in patients treated with esophagectomy

M. Orringer, A. Chang, W. Lynch, 2019, Michigan Journal of Medicine.

Intensive induction chemotherapy and radiation for organ preservation in patients with advanced resectable head and neck carcinoma.

P. McLaughlin, G. Wolf, A. Thornton, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Radiation C oncurrent W ith G emcitabine f or L ocally Advanced H ead a nd N eck C ancer: A P hase I T rial a nd Intracellular D rug I ncorporation S tudy

L. Dawson, T. Lawrence, A. Eisbruch, 2001 .

Concurrent chemoradiotherapy in head and neck cancer

S. Urba, 1999, Current oncology reports.

NCCN practice guidelines for head and neck cancer. National Comprehensive Cancer Network.

J. Shah, G. Laramore, D. Pfister, 1998, Oncology.

Survivorship: Fatigue, Version 1.2014: Clinical Practice Guidelines in Oncology

A. King, J. Montoya, Deborah A. Freedman-Cass, 2014 .

Induction chemotherapy for organ preservation in advanced squamous cell carcinoma of the oral cavity and oropharynx.

G. Wolf, M. Hazuka, S. Urba, 1994, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

NCCN Guidelines Insights: Antiemesis, Version 2.2017.

Eun Jeong Kim, P. Bierman, D. Ettinger, 2017, Journal of the National Comprehensive Cancer Network : JNCCN.

NCCN Guidelines Insights: Antiemesis, Version 2.2017.

Eun Jeong Kim, P. Bierman, D. Ettinger, 2017, Journal of the National Comprehensive Cancer Network : JNCCN.

NCCN Antiemesis Panel Members

D. Ettinger, M. Kris, H. Rugo, 2010 .

AntiemesisPractice Guidelines in Oncology TM

P. Bierman, D. Ettinger, M. Kris, 2009 .

Antiemesis clinical practice guidelines in oncology.

P. Bierman, D. Ettinger, M. Kris, 2004, Journal of the National Comprehensive Cancer Network : JNCCN.

Immune Reactivity Does Not Predict Chemotherapy Response, Organ Preservation, or Survival in Advanced Laryngeal Cancer

L. Dawson, A. Eisbruch, C. Bradford, 2002, The Laryngoscope.

Planned Early Neck Dissection Before Radiation for Persistent Neck Nodes After Induction Chemotherapy

A. Eisbruch, C. Bradford, G. Wolf, 1997, The Laryngoscope.

Long‐Term Results of a Phase III Randomized Trial of Postoperative Radiotherapy With or Without Carboplatin in Patients With High‐Risk Head and Neck Cancer

D. Heron, M. Karamouzis, J. Grandis, 2008, The Laryngoscope.

NCCN antiemesis practice guidelines.

D. Ettinger, M. Kris, M. Levy, 1997, Oncology.

NCCN Practice Guidelines for Cancer Pain.

S. Hassenbusch, C. Benedetti, C. Cleeland, 2000, Oncology.

Survivorship: immunizations and prevention of infections, version 2.2014.

A. King, J. Montoya, Deborah A. Freedman-Cass, 2014, Journal of the National Comprehensive Cancer Network : JNCCN.

Adult Cancer Pain, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology.

M. Kamdar, C. Cleeland, S. Mackey, 2019, Journal of the National Comprehensive Cancer Network : JNCCN.

Adult cancer pain.

C. Benedetti, A. Abernethy, M. Dwyer, 2010, Journal of the National Comprehensive Cancer Network : JNCCN.

Adult cancer pain.

C. Benedetti, C. Cleeland, G. Montana, 2007, Journal of the National Comprehensive Cancer Network : JNCCN.

Classification of TP53 mutations and HPV predict survival in advanced larynx cancer

A. Eisbruch, T. Carey, C. Bradford, 2016, The Laryngoscope.

Clinical roundtable monograph. Treatment of chemotherapy-induced nausea and vomiting: a post-MASCC 2010 discussion.

M. Kris, L. Schwartzberg, S. Urba, 2011, Clinical advances in hematology & oncology : H&O.

Phase II trial of erlotinib in gastroesophageal junction and gastric adenocarcinomas: SWOG 0127.

C. Fenoglio-Preiser, C. Blanke, J. Abbruzzese, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Squamous cell carcinoma of the esophagus: treat with how many modalities?

M. Iannettoni, M. Suntharalingam, M. Koshy, 2009, Seminars in oncology.

Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma.

M. Iannettoni, M. Orringer, M. Strawderman, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A phase II study of imatinib in patients with advanced anaplastic thyroid cancer.

T. Giordano, F. Worden, J. Sisson, 2010, Thyroid : official journal of the American Thyroid Association.

Biomarkers in advanced larynx cancer

A. Eisbruch, N. D’Silva, T. Carey, 2014, The Laryngoscope.

Concurrent chemotherapy and radiation therapy followed by transhiatal esophagectomy for local-regional cancer of the esophagus.

M. Orringer, S. Husted, M. Zahurak, 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Single-cycle induction chemotherapy selects patients with advanced laryngeal cancer for combined chemoradiation: a new treatment paradigm.

A. Eisbruch, C. Bradford, G. Wolf, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Many cancer survivors experience menopaus-NCCN Survivorship , Version 2 . 2017 Clinical Practice Guidelines in Oncology

A. King, J. Montoya, Deborah A. Freedman-Cass, 2017 .

NCCN Guidelines Insights: Survivorship, Version 1.2016.

A. King, J. Montoya, Deborah A. Freedman-Cass, 2016, Journal of the National Comprehensive Cancer Network : JNCCN.

Results of primary and adjuvant CT-based 3-dimensional radiotherapy for malignant tumors of the paranasal sinuses.

M. Martel, H. Sandler, W. Roa, 1994, International journal of radiation oncology, biology, physics.

Treatment of malignant pheochromocytomas with 131-I metaiodobenzylguanidine and chemotherapy.

B. Shulkin, J. Sisson, B. Shapiro, 1999, American journal of clinical oncology.

Correlation of cellular immunity with human papillomavirus 16 status and outcome in patients with advanced oropharyngeal cancer.

A. Eisbruch, N. D’Silva, T. Carey, 2010, Archives of otolaryngology--head & neck surgery.

EGFR, p16, HPV Titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer.

C. Tsien, A. Eisbruch, N. D’Silva, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Chemoselection as a strategy for organ preservation in advanced oropharynx cancer: response and survival positively associated with HPV16 copy number.

C. Tsien, A. Eisbruch, N. D’Silva, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A phase 2 trial of surgery with perioperative INGN 201 (Ad5CMV-p53) gene therapy followed by chemoradiotherapy for advanced, resectable squamous cell carcinoma of the oral cavity, oropharynx, hypopharynx, and larynx: report of the Southwest Oncology Group.

M. Leblanc, J. Moon, G. Wolf, 2009, Archives of otolaryngology--head & neck surgery.

Tamoxifen Therapy In Patients With Recurrent Laryngeal Squamous Carcinoma

T. Carey, G. Wolf, A. Forastiere, 1990, The Laryngoscope.

Voice and swallowing outcomes of an organ-preservation trial for advanced laryngeal cancer.

K. Fung, C. Tsien, A. Eisbruch, 2005, International journal of radiation oncology, biology, physics.

Potentially Curable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline.

J. Berlin, A. Maitra, A. Khorana, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Metastatic Pancreatic Cancer: ASCO Clinical Practice Guideline Update.

A. Khorana, P. Philip, M. Shah, 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Palliative care. Clinical practice guidelines in oncology.

J. V. Von Roenn, C. Ritchie, J. Temel, 2003, Journal of the National Comprehensive Cancer Network : JNCCN.

Metastatic Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline.

A. Khorana, P. Philip, M. Shah, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II trial of biweekly gemcitabine and paclitaxel with recurrent or metastatic squamous cell carcinoma of the head and neck: Southwest Oncology Group study S0329

J. Moon, G. Wolf, F. Worden, 2014, Head & neck.

Phase II Trial of Docetaxel Chemotherapy in Patients with Incurable Adenocarcinoma of the Esophagus

S. Piantadosi, E. Heath, J. Marshall, 2002, Investigational New Drugs.

Potentially Curable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update.

J. Berlin, A. Maitra, A. Khorana, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Efficacy of induction selection chemotherapy vs primary surgery for patients with advanced oral cavity carcinoma.

L. Rozek, A. Eisbruch, T. Carey, 2014, JAMA otolaryngology-- head & neck surgery.

Alternating and concurrent chemotherapy and radiotherapy for unresectable head and neck carcinoma

G. Wolf, A. Thornton, A. Forastiere, 1993 .

Extranodal non-Hodgkin's lymphoma of the head and neck: presentation in the facial bones.

G. Wolf, K. Stenson, S. Urba, 1996, American journal of otolaryngology.

Intensive recombinant interleukin‐2 and alpha‐interferon therapy in patients with advanced head and neck squamous carcinoma

G. Wolf, P. Amrein, A. Forastiere, 1993, Cancer.

Palliative Care Version 1.2016.

J. Kutner, E. Szmuilowicz, J. Temel, 2016, Journal of the National Comprehensive Cancer Network : JNCCN.

NCCN Guidelines Insights: Palliative Care, Version 2.2017.

J. Kutner, E. Szmuilowicz, J. Temel, 2017, Journal of the National Comprehensive Cancer Network : JNCCN.

Pemetrexed in combination with cisplatin versus cisplatin monotherapy in patients with recurrent or metastatic head and neck cancer

D. Shin, C. Reuter, R. Hitt, 2012, Cancer.

Nonpharmacologic pain management in terminal care.

S. Urba, 1996, Clinics in geriatric medicine.

A Phase II Biomarker-Embedded Study of Lapatinib plus Capecitabine as First-line Therapy in Patients with Advanced or Metastatic Gastric Cancer

H. Lenz, M. Pishvaian, P. Wilson, 2016, Molecular Cancer Therapeutics.

Pembrolizumab in previously treated metastatic esophageal cancer: Longer term follow-up from the phase 2 KEYNOTE-180 Study.

Sung-Bae Kim, M. Shah, F. Lordick, 2019, Journal of Clinical Oncology.

Tobacco Use in Human Papillomavirus–Positive Advanced Oropharynx Cancer Patients Related to Increased Risk of Distant Metastases and Tumor Recurrence

F. Feng, A. Eisbruch, T. Carey, 2010, Clinical Cancer Research.

Survival Rates Using Individualized Bioselection Treatment Methods in Patients With Advanced Laryngeal Cancer

A. Eisbruch, C. Bradford, G. Wolf, 2017, JAMA otolaryngology-- head & neck surgery.

Survivorship: sexual dysfunction (female), version 1.2013.

S. Edge, R. Carlson, A. King, 2014, Journal of the National Comprehensive Cancer Network : JNCCN.

Recurrences near base of skull after IMRT for head-and-neck cancer: implications for target delineation in high neck and for parotid gland sparing.

L. Dawson, M. Schipper, A. Eisbruch, 2004, International journal of radiation oncology, biology, physics.

NCCN Guidelines Insights: Survivorship, Version 1.2016.

A. King, J. Montoya, Deborah A. Freedman-Cass, 2020, Journal of the National Comprehensive Cancer Network : JNCCN.

NCCN Palliative Care Panel Members

C. Benedetti, S. Block, D. Spiegel, 2010 .

Survivorship, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology.

A. King, J. Montoya, Deborah A. Freedman-Cass, 2017, Journal of the National Comprehensive Cancer Network : JNCCN.

Survivorship: sleep disorders, version 1.2014.

A. King, J. Montoya, Deborah A. Freedman-Cass, 2014, Journal of the National Comprehensive Cancer Network : JNCCN.

Survivorship: introduction and definition. Clinical practice guidelines in oncology.

S. Edge, R. Carlson, A. King, 2014, Journal of the National Comprehensive Cancer Network : JNCCN.

Preoperative chemoradiation for the treatment of locoregional esophageal cancer: the standard of care?

S. Urba, Bryan J Schneider, Susan G Urba, 2007, Seminars in radiation oncology.

Survivorship: sexual dysfunction (male), version 1.2013.

S. Edge, R. Carlson, A. King, 2014, Journal of the National Comprehensive Cancer Network : JNCCN.

A phase II evaluation of a 3-hour infusion of paclitaxel (P), cisplatin (CDDP) & 5-fluorouracil (5FU) in patients with advanced or recurrent squamous cell carcinoma of the head & neck (SCCHN): A Southwest Oncology Group Study.

S. Dakhil, J. Moon, W. Samlowski, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Combined modality therapy of esophageal cancer--standard of care?

S. Urba, 2002, Surgical oncology clinics of North America.

Gemcitabine and Cisplatin for Patients with Metastatic or Recurrent Esophageal Carcinoma: A Southwest Oncology Group Study

K. Chansky, J. Abbruzzese, P. Vanveldhuizen, 2004, Investigational New Drugs.

Docetaxel, cisplatin, and fluorouracil induction chemotherapy followed by accelerated fractionation/concomitant boost radiation and concurrent cisplatin in patients with advanced squamous cell head and neck cancer: A Southwest Oncology Group phase II trial (S0216)

J. Moon, G. Wolf, E. Hanna, 2009, Head & neck.

Pre-operative chemoradiation followed by post-operative adjuvant therapy with tetrathiomolybdate, a novel copper chelator, for patients with resectable esophageal cancer

S. Merajver, M. Orringer, A. Chang, 2013, Investigational New Drugs.

Pemetrexed in combination with cisplatin versus cisplatin monotherapy in East Asian patients with recurrent or metastatic head and neck cancer: Results of an exploratory subgroup analysis of a phase III trial

R. Cheng, M. Orlando, R. Hong, 2013, Asia-Pacific journal of clinical oncology.

Survivorship: cognitive function, version 1.2014.

A. King, J. Montoya, Deborah A. Freedman-Cass, 2014, Journal of the National Comprehensive Cancer Network : JNCCN.

Survivorship: cognitive function, version 1.2014.

A. King, J. Montoya, Deborah A. Freedman-Cass, 2014, Journal of the National Comprehensive Cancer Network : JNCCN.

What is palliative care?

J. V. Von Roenn, C. Ritchie, J. Temel, 2015, Journal of palliative medicine.

Chemotherapy followed by accelerated fractionated radiation for larynx preservation in patients with advanced laryngeal cancer.

M. Strawderman, A. Eisbruch, C. Bradford, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

NCCN Guidelines ® Insights Palliative Care , Version 2 . 2017 Featured Updates to the NCCN Guidelines

J. Kutner, E. Szmuilowicz, J. Temel, 2017 .

Phase II trial evaluating imatinib (I) in patients (pts) with anaplastic thyroid carcinoma (ATC).

T. Giordano, F. Worden, J. Sisson, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Organ preservation in multimodality therapy of head and neck cancer.

G. Wolf, S. Urba, 1991, Hematology/Oncology Clinics of North America.

Phase II evaluation of eribulin mesylate (E7389, NSC 707389) in patients with metastatic or recurrent squamous cell carcinoma of the head and neck: Southwest Oncology Group trial S0618

M. Leblanc, S. Ou, J. Moon, 2011, Investigational New Drugs.

Single-agent paclitaxel and paclitaxel plus ifosfamide in the treatment of head and neck cancer.

A. Forastiere, S. Urba, 1995, Seminars in oncology.

Split‐course accelerated radiation therapy combined with carboplatin and 5‐fluorouracil for palliation of metastatic or unresectable carcinoma of the esophagus

S. Urba, Andrew T. Turrisi, 1995, Cancer.

Acceleration of hyperfractionated chemoradiation regimen for advanced head and neck cancer

L. Dawson, C. Tsien, A. Eisbruch, 2007, Head & neck.

Supportive Care During Curative Treatment

S. Urba, Danielle Karsies, Suzette Walker, 2017 .

Phase III randomized trial of postoperative radiotherapy (RT) with or without carboplatin (Cb) in patients (pts) with head and neck squamous cell carcinoma (HNSCC)

D. Heron, M. Karamouzis, A. Argiris, 2007 .

Phase 2 Trial of AT-101 in Combination With Docetaxel for Recurrent, Locally Advanced, or Metastatic Head-and-Neck Squamous Cell Carcinoma (HNSCC)

A. Eisbruch, C. Bradford, G. Wolf, 2014 .

Neoadjuvant twice daily chemoradiotherapy for esophageal cancer: Treatment-related mortality and long-term outcomes

M. Orringer, J. Hayman, J. Mchugh, 2017, Advances in radiation oncology.

Individual Participant Data Network Meta-Analysis of Neoadjuvant Chemotherapy or Chemoradiotherapy in Esophageal or Gastroesophageal Junction Carcinoma

V. Gebski, J. Pignon, P. Schlag, 2023, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Survivorship: screening for cancer and treatment effects, version 2.2014.

A. King, J. Montoya, Deborah A. Freedman-Cass, 2014, Journal of the National Comprehensive Cancer Network : JNCCN.

Circulating CD4‐positive lymphocyte levels as predictor of response to induction chemotherapy in patients with advanced laryngeal cancer

A. Eisbruch, C. Bradford, G. Wolf, 2014, Head & neck.

A randomized phase II study of vismodegib (V), a hedgehog (HH) pathway inhibitor, combined with FOLFOX in patients (pts) with advanced gastric and gastroesophageal junction (GEJ) carcinoma: A New York Cancer Consortium led study.

J. Sparano, Y. Janjigian, E. Chan, 2013 .

Survivorship: pain version 1.2014.

A. King, J. Montoya, Deborah A. Freedman-Cass, 2014, Journal of the National Comprehensive Cancer Network : JNCCN.

Survivorship: sleep disorders, version 1.2014.

A. King, J. Montoya, Deborah A. Freedman-Cass, 2014, Journal of the National Comprehensive Cancer Network : JNCCN.

NCCN guidelines for survivorship expanded to address two common conditions.

E. Kvale, S. Urba, 2014, The Journal of the National Comprehensive Cancer Network.

Workshop report: Organ preservation strategies in advanced head and neck cancer—Current status and future directions

K. Ang, D. Kraus, T. Pajak, 1999, Head & neck.

NCCN Guidelines Insights: Palliative Care, Version 2.2017.

J. Kutner, E. Szmuilowicz, J. Temel, 2017, The Journal of the National Comprehensive Cancer Network.

Palliative Care Version 1.2016.

J. Kutner, E. Szmuilowicz, J. Temel, 2016, Journal of the National Comprehensive Cancer Network : JNCCN.

Vismodegib (V), a hedgehog (HH) pathway inhibitor, combined with FOLFOX for first-line therapy of patients (pts) with advanced gastric and gastroesophageal junction (GEJ) carcinoma: A New York Cancer Consortium led phase II randomized study.

J. Sparano, Y. Janjigian, P. Christos, 2013 .

A Phase II Trial Evaluating Weekly Docetaxel and Capecitabine in Patients with Metastatic or Advanced, Locally Recurrent Head and Neck Cancers

Jingsong Zhang, F. Worden, J. Lee, 2010, Cancer investigation.

Chemo-selection as a strategy for organ preservation in patients with T4 laryngeal squamous cell carcinoma

C. Tsien, A. Eisbruch, C. Bradford, 2007 .

Pre-operative chemoradiation with cisplatin (CDDP), 5-fluorouracil (5FU), and paclitaxel (Tax), followed by surgery and adjuvant chemotherapy, for loco-regional esophageal carcinoma.

M. Orringer, J. Hayman, J. Scheiman, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.